Raymond James Financial Begins Coverage on Healthpeak Properties (NYSE:DOC)

Stock analysts at Raymond James Financial initiated coverage on shares of Healthpeak Properties (NYSE:DOC) in a research note issued on Wednesday. The firm set a “market perform” rating on the real estate investment trust’s stock.

Other research analysts have also issued reports about the company. Wells Fargo & Company increased their price objective on Healthpeak Properties from $18.00 to $20.00 and gave the company an “equal weight” rating in a report on Monday, June 1st. Royal Bank Of Canada upped their target price on Healthpeak Properties from $20.00 to $21.00 and gave the company an “outperform” rating in a research report on Thursday, May 14th. BMO Capital Markets increased their price target on shares of Healthpeak Properties from $20.00 to $24.00 and gave the stock an “outperform” rating in a report on Monday. Wall Street Zen raised shares of Healthpeak Properties from a “sell” rating to a “hold” rating in a research report on Sunday, May 10th. Finally, Morgan Stanley restated an “equal weight” rating and set a $22.00 price objective (up from $20.00) on shares of Healthpeak Properties in a research note on Thursday, June 11th. Three equities research analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the company’s stock. According to MarketBeat, Healthpeak Properties has a consensus rating of “Hold” and a consensus target price of $19.86.

Healthpeak Properties Stock Performance

Shares of DOC traded down $0.11 during trading hours on Wednesday, reaching $19.99. 163,096 shares of the company traded hands, compared to its average volume of 9,156,978. The company has a quick ratio of 2.96, a current ratio of 2.96 and a debt-to-equity ratio of 1.15. The business has a fifty day moving average price of $18.49 and a 200-day moving average price of $17.52. Healthpeak Properties has a 12-month low of $15.70 and a 12-month high of $20.82. The stock has a market capitalization of $13.78 billion, a P/E ratio of 62.46, a P/E/G ratio of 3.19 and a beta of 1.05.

Healthpeak Properties (NYSE:DOC) last issued its earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.43 by $0.02. Healthpeak Properties had a return on equity of 2.61% and a net margin of 7.73%.The company had revenue of $752.95 million during the quarter, compared to analyst estimates of $694.59 million. During the same quarter last year, the business posted $0.46 EPS. The firm’s quarterly revenue was up 7.1% on a year-over-year basis. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. Equities analysts anticipate that Healthpeak Properties will post 1.74 EPS for the current fiscal year.

Insider Activity

In other news, insider Scott R. Bohn sold 10,989 shares of the business’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $19.45, for a total transaction of $213,736.05. Following the completion of the sale, the insider owned 7,636 shares of the company’s stock, valued at $148,520.20. The trade was a 59.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.23% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Healthpeak Properties

Institutional investors have recently bought and sold shares of the company. State Street Corp boosted its stake in shares of Healthpeak Properties by 1.8% in the third quarter. State Street Corp now owns 49,498,109 shares of the real estate investment trust’s stock worth $947,889,000 after acquiring an additional 895,460 shares during the last quarter. JPMorgan Chase & Co. boosted its holdings in Healthpeak Properties by 8.6% in the 4th quarter. JPMorgan Chase & Co. now owns 30,674,812 shares of the real estate investment trust’s stock valued at $493,251,000 after purchasing an additional 2,438,278 shares during the last quarter. Fuller & Thaler Asset Management Inc. grew its position in Healthpeak Properties by 19.2% in the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 29,648,260 shares of the real estate investment trust’s stock worth $476,744,000 after acquiring an additional 4,776,056 shares during the period. Geode Capital Management LLC grew its holdings in shares of Healthpeak Properties by 0.6% during the 4th quarter. Geode Capital Management LLC now owns 19,534,041 shares of the real estate investment trust’s stock worth $312,959,000 after purchasing an additional 123,274 shares during the period. Finally, Invesco Ltd. increased its position in shares of Healthpeak Properties by 9.9% during the 4th quarter. Invesco Ltd. now owns 18,298,776 shares of the real estate investment trust’s stock worth $294,244,000 after purchasing an additional 1,648,012 shares during the last quarter. 93.57% of the stock is currently owned by institutional investors and hedge funds.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.